The role of phosphorylation of proteoglycans in the intracellular sorting and control of biosynthesis of these molecules will be investigated using tissue culture, radioisotopic labeling and detailed chemical analysis. The detailed structure of the modified linkage region for the Swarm rat chondrosarcoma chondroitin sulfate proteoglycan and the EHS heparan sulfate proteoglycan will be determined using such methods as enzymatic digestions, methylation, GC-mass spectrophotometry and 31 P NMR. Enzymatic digestions will also be utilized to identify the sequence of phosphorylated peptides, and, to order the substitution sites with the proteoglycan. The phosphorylating enzymes, including the 2-phosphoxylose phosphorylating enzyme will be characterized as to donor and substrate specificity, size, location and chemical composition. The subcellular distribution of modifying enzyme(s) will be determined by standard subcellular fractionation and analysis. In addition, the regulation of the modification will be examined with cultured cells perturbed by reagents such as insulin, calmodulin inhibitors and cyclic AMP altering drugs, as well as by monesin and other blockers of intracellular transport.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR032372-05
Application #
3156277
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1983-07-01
Project End
1991-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Gupta, P; Oegema Jr, T R; Brazil, J J et al. (2000) Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix pr Blood 95:147-55
Gupta, P; Oegema Jr, T R; Brazil, J J et al. (1998) Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 92:4641-51
Sundaram, L; Deloria, L B; Oegema Jr, T R (1997) Mercuric salt-catalyzed removal of unsaturated glucuronic acid from chondroitinase-treated proteochondroitin sulfate. Arch Biochem Biophys 338:213-9
Drake, S L; Klein, D J; Mickelson, D J et al. (1992) Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide. J Cell Biol 117:1331-41
Faassen, A E; Schrager, J A; Klein, D J et al. (1992) A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-31
Platt, J L; Trescony, P; Lindman, B et al. (1990) Heparin and heparan sulfate delimit nephron formation in fetal metanephric kidneys. Dev Biol 139:338-48
Klein, D J; Oegema Jr, T R; Brown, D M (1989) Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats. Diabetes 38:130-9
Trescony, P V; Oegema Jr, T R; Farnam, B J et al. (1989) Analysis of heparan sulfate from the Engelbreth-Holm-Swarm (EHS) tumor. Connect Tissue Res 19:219-42
Klein, D J; Brown, D M; Oegema, T R et al. (1988) Glomerular basement membrane proteoglycans are derived from a large precursor. J Cell Biol 106:963-70